Study To Evaluate The Pharmacokinetics Of Jaktinib Hydrochloride Tablets In Subjects With Hepatic Impairment And Normal Hepatic Function
Latest Information Update: 30 Nov 2022
At a glance
- Drugs Gecaxitinib hydrochloride (Primary)
- Indications Alopecia areata; Ankylosing spondylitis; Atopic dermatitis; COVID-19 pneumonia; Idiopathic pulmonary fibrosis; Myelofibrosis
- Focus Pharmacokinetics
- Sponsors Suzhou Zelgen Biopharmaceuticals
- 28 Nov 2022 Status changed from recruiting to completed.
- 29 Nov 2021 Status changed from not yet recruiting to recruiting.
- 13 Aug 2021 New trial record